F61F12

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameF61F12
Drug Alias Nameanti-Fas mAb (IMED)F61F12
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionApoptosis-mediating surface antigen FAS inhibitors
TargetsApoptosis-mediating surface antigen FAS
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIMED AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIMED AB
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A